Pfizer Takes Action Against Generics At FDA

Law360, New York (February 8, 2006, 12:00 AM EST) -- Generic versions of Pfizer Inc.’s antibiotic Zithromax made by Teva Pharmaceuticals U.S.A. and Novartis subsidiary Sandoz Inc. do not accurately describe the drugs' active ingredients and are a danger to consumers, according to petition filed by Pfizer with the U.S. Food and Drug Administration Wednesday.

The petition is the latest in a series of maneuvers that have targeted the generic companies’ at-risk launch of the drug, which the FDA approved for generic manufacture in November 2005. The main patent for Zithromax expired on Nov. 1, although...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.